| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9892 |
| Human Intestinal Absorption | HIA+ | 0.9932 |
| Caco-2 Permeability | Caco2+ | 0.7924 |
| P-glycoprotein Substrate | Substrate | 0.8370 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8674 |
| Non-inhibitor | 0.6816 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5372 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4401 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8192 |
| CYP450 2D6 Substrate | Substrate | 0.6599 |
| CYP450 3A4 Substrate | Substrate | 0.7803 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7994 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8162 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6335 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8059 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8072 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8335 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9038 |
| Non-inhibitor | 0.9086 |
| AMES Toxicity | Non AMES toxic | 0.6935 |
| Carcinogens | Non-carcinogens | 0.9341 |
| Fish Toxicity | High FHMT | 0.9891 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9773 |
| Honey Bee Toxicity | High HBT | 0.5090 |
| Biodegradation | Not ready biodegradable | 0.9696 |
| Acute Oral Toxicity | III | 0.7187 |
| Carcinogenicity (Three-class) | Non-required | 0.5810 |